August 17 -- Shandong Wohua Pharmaceutical (002107.SZ) posted a loss of 1.8 million yuan in the first half of 2011, with losses per share of 0.01 yuan, reports p5w.net, citing a company filing. Sales revenue in the same period grew 50.96 percent to 68.9 million yuan.

The Weifang-based company attributed the increase in sales revenue to higher sales of cardiological drugs and lower operation costs.

Wohua Pharmaceutical predicted that it will emerge from losses in the first three quarters of 2011. Net profit in the first three quarters is estimated to be as high as five million yuan.

The company posted a loss of 20.76 million yuan and a loss per share of 0.13 yuan in the first six months last year.